LivaNova (LIVN) Income from Non-Controlling Interests (2017)
LivaNova's (LIVN) quarterly Income from Non-Controlling Interests came in at $1.9 million in Q4 2017, up 334.82% quarter-over-quarter from -$830000.0 in Q3 2017.
LivaNova (LIVN) Income from Non-Controlling Interests (2017) Analysis & Trends
LivaNova has disclosed Income from Non-Controlling Interests across 1 years of filings, most recently posting $1.9 million for Q4 2017.
- Income from Non-Controlling Interests for Q4 2017 came in at $1.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $1.3 million (changed N/A YoY), and the FY2017 annual result was $1.3 million, down 98.03% from the prior year.
- Income from Non-Controlling Interests came in at $1.9 million for Q4 2017 at LivaNova, up from -$830000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $2.0 million in Q1 2017 to a low of -$1.8 million in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 100,000.00 |
| 10 | LivaNova | 4.29 Bn | 3.71 Bn | 243.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1.95 Mn |
| Sep 30, 2017 | -830,000.00 |
| Jun 30, 2017 | -1.80 Mn |
| Mar 31, 2017 | 1.96 Mn |